LAURA JERNIGAN: Open Payments
NPI 1184220402 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,605 in 149 payments from 38 companies in 2025. Trend: 2023 $3,524 · 2024 $2,267 · 2025 $3,605
Food & beverage: $3,482Education: $124
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $299 |
| ABBVIE INC. | 18 | $275 |
| HARMONY BIOSCIENCES LLC | 7 | $221 |
| PFIZER INC. | 9 | $194 |
| SK Life Science, Inc. | 6 | $182 |
| Novartis Pharmaceuticals Corporation | 10 | $177 |
| Biogen, Inc. | 6 | $143 |
| JAZZ PHARMACEUTICALS INC. | 5 | $124 |
| Celgene Corporation | 4 | $118 |
| ACADIA Pharmaceuticals Inc | 5 | $117 |
Products named: KESIMPTA, QULIPTA, WAKIX, Leqembi, ZEPOSIA, NUPLAZID, VYEPTI, FYCOMPA.
Industry payments across GA — which companies pay providers there.
